Sharon Bio - Medicine Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported revenue was INR 598.33 million compared to INR 449.11 million a year ago. Net income was INR 94.66 million compared to INR 40.23 million a year ago. Basic earnings per share from continuing operations was INR 16.45 compared to INR 6.99 a year ago.
For the nine months, revenue was INR 1,544.05 million compared to INR 1,403.04 million a year ago. Net income was INR 172 million compared to INR 129.94 million a year ago. Basic earnings per share from continuing operations was INR 29.88 compared to INR 22.58 a year ago.